View in EDS

Phosphatidylserine as a tumor target for CAR-T cell therapy.

Saved in:
Bibliographic Details
Title: Phosphatidylserine as a tumor target for CAR-T cell therapy.
Authors: Martín-Otal C; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Sánchez-Moreno I; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Gómez-Morón A; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain., Castro C; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Casares N; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Navarro F; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Gorraiz M; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Justicia-Lirio P; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain., Pareja F; Department of Nuclear Medicine, CIMA Universidad de Navarra, Pamplona, Spain., Collantes M; Department of Nuclear Medicine, CIMA Universidad de Navarra, Pamplona, Spain., Peñuelas I; Department of Nuclear Medicine, CIMA Universidad de Navarra, Pamplona, Spain., Iñarrairaegui M; IdiSNA, Pamplona, Spain.; Liver Unit, University Clinic of Navarra, Pamplona, Spain., Sangro B; IdiSNA, Pamplona, Spain.; Liver Unit, University Clinic of Navarra, Pamplona, Spain., Vivas I; IdiSNA, Pamplona, Spain.; Radiology, University Clinic of Navarra, Pamplona, Spain., Larrayoz M; IdiSNA, Pamplona, Spain.; Hemato-Oncology Program, CIMA Universidad de Navarra, Pamplona, Spain., Rodriguez JR; IdiSNA, Pamplona, Spain.; Hemato-Oncology Program, CIMA Universidad de Navarra, Pamplona, Spain., Prosper F; IdiSNA, Pamplona, Spain.; Hematology and Cell Therapy Department, University Clinic of Navarra, Pamplona, Spain., Hervas-Stubbs S; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain., Martin-Cofreces N; CIBERCV, Madrid, Community of Madrid, Spain., Lasarte JJ; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain jjlasarte@unav.es.; IdiSNA, Pamplona, Spain., Lozano T; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2025 Feb 23; Vol. 13 (2). Date of Electronic Publication: 2025 Feb 23.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39988346
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phosphatidylserine as a tumor target for CAR-T cell therapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Martín-Otal+C%22">Martín-Otal C</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Sánchez-Moreno+I%22">Sánchez-Moreno I</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Gómez-Morón+A%22">Gómez-Morón A</searchLink>; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Castro+C%22">Castro C</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Casares+N%22">Casares N</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Navarro+F%22">Navarro F</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Gorraiz+M%22">Gorraiz M</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Justicia-Lirio+P%22">Justicia-Lirio P</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Pareja+F%22">Pareja F</searchLink>; Department of Nuclear Medicine, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Collantes+M%22">Collantes M</searchLink>; Department of Nuclear Medicine, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Peñuelas+I%22">Peñuelas I</searchLink>; Department of Nuclear Medicine, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Iñarrairaegui+M%22">Iñarrairaegui M</searchLink>; IdiSNA, Pamplona, Spain.; Liver Unit, University Clinic of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Sangro+B%22">Sangro B</searchLink>; IdiSNA, Pamplona, Spain.; Liver Unit, University Clinic of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Vivas+I%22">Vivas I</searchLink>; IdiSNA, Pamplona, Spain.; Radiology, University Clinic of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Larrayoz+M%22">Larrayoz M</searchLink>; IdiSNA, Pamplona, Spain.; Hemato-Oncology Program, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez+JR%22">Rodriguez JR</searchLink>; IdiSNA, Pamplona, Spain.; Hemato-Oncology Program, CIMA Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Prosper+F%22">Prosper F</searchLink>; IdiSNA, Pamplona, Spain.; Hematology and Cell Therapy Department, University Clinic of Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Hervas-Stubbs+S%22">Hervas-Stubbs S</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martin-Cofreces+N%22">Martin-Cofreces N</searchLink>; CIBERCV, Madrid, Community of Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Lasarte+JJ%22">Lasarte JJ</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain jjlasarte@unav.es.; IdiSNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lozano+T%22">Lozano T</searchLink>; Program of Immunology and Inmunoterapy, CIMA Universidad de Navarra, Pamplona, Spain.; IdiSNA, Pamplona, Spain.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2025 Feb 23; Vol. 13 (2). <i>Date of Electronic Publication: </i>2025 Feb 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39988346
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2024-009468
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Phosphatidylserine as a tumor target for CAR-T cell therapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Martín-Otal C
      – PersonEntity:
          Name:
            NameFull: Sánchez-Moreno I
      – PersonEntity:
          Name:
            NameFull: Gómez-Morón A
      – PersonEntity:
          Name:
            NameFull: Castro C
      – PersonEntity:
          Name:
            NameFull: Casares N
      – PersonEntity:
          Name:
            NameFull: Navarro F
      – PersonEntity:
          Name:
            NameFull: Gorraiz M
      – PersonEntity:
          Name:
            NameFull: Justicia-Lirio P
      – PersonEntity:
          Name:
            NameFull: Pareja F
      – PersonEntity:
          Name:
            NameFull: Collantes M
      – PersonEntity:
          Name:
            NameFull: Peñuelas I
      – PersonEntity:
          Name:
            NameFull: Iñarrairaegui M
      – PersonEntity:
          Name:
            NameFull: Sangro B
      – PersonEntity:
          Name:
            NameFull: Vivas I
      – PersonEntity:
          Name:
            NameFull: Larrayoz M
      – PersonEntity:
          Name:
            NameFull: Rodriguez JR
      – PersonEntity:
          Name:
            NameFull: Prosper F
      – PersonEntity:
          Name:
            NameFull: Hervas-Stubbs S
      – PersonEntity:
          Name:
            NameFull: Martin-Cofreces N
      – PersonEntity:
          Name:
            NameFull: Lasarte JJ
      – PersonEntity:
          Name:
            NameFull: Lozano T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 02
              Text: 2025 Feb 23
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1